Cited by 44Diabetes and associated disordersDiabetes Management and ResearchPancreatic function and diabetes

Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies: Solitary islet cell antibody positivity

Open access
Andersson, Cecilia, Kolmodin, Martin, Ivarsson, Sten-Anders, Carlsson, Annelie, Forsander, Gun, Lindblad, Bengt, Ludvigsson, Johnny, Kockum, Ingrid +7 more·2014·Pediatric Diabetes

Abstract

AIMS: The aim of this study was to explore whether islet cell antibodies (ICA) could be identified in children with newly onset diabetes mellitus but negative for autoantibodies against glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A), insulin (IAA), or any of the three variants with arginine (R), tryptophan (W), or glutamine (Q) at position 325 of the zinc transporter 8 (ZnT8A). METHODS: A population-based analysis of autoantibodies was performed from 1 May 2005 to 2 September 2010 in Swedish children newly diagnosed with diabetes. ICA was analyzed with an enzyme-linked immunosorbent assay and if positive, reanalyzed in the classical ICA immunofluorescence assay, in 341 samples among 3545 children who had been tested negative for all of GADA, IA-2A, IAA, or ZnT8A (R, W, Q). RESULTS: An isolated positivity for ICA was identified in 5.0% (17/341) of the newly diagnosed children. The levels of ICA in positive subjects ranged from 3 to 183 JDF-U (median 30). This finding increased the diagnostic sensitivity of islet autoimmunity as 3204/3545 patients (90.4%) were islet autoantibody positive without the ICA analyses and 3221 patients (90.9%) were positive with the inclusion of ICA. CONCLUSIONS: The finding of an isolated positivity for ICA despite negativity for GADA, IA-2A, IAA, and ZnT8A (R, W, Q) suggests that still another yet unidentified autoantigen(s) may contribute to the ICA immunofluorescence. Hence, ICA is important to analyze in type 1 diabetes children and adolescents that would otherwise be islet autoantibody negative.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pedi.12093

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Approximately 10% of individuals presenting with new-onset diabetes express only a single autoantibody.

    “approximately 10% of individuals presenting with new-onset diabetes express only a single autoantibody (445).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [445]

    The Results section ('ICA positivity in children enrolled in the Better Diabetes Diagnosis Study'; page unavailable) reports a single autoantibody—ICA—in 17 of 229 children with type 1 diabetes who had tested negative for the other autoantibodies, or about 7%. That is a selected subgroup, not approximately 10% of all individuals presenting with new-onset diabetes; the paper does not give the claimed overall prevalence of exactly one autoantibody. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Andersson, C., Kolmodin, M., Ivarsson, S.-A., Carlsson, A., Forsander, G., Lindblad, B., Ludvigsson, J., Kockum, I., Marcus, C., Samuelsson, U., Örtqvist, E., Lernmark, Å., Elding Larsson, H., Törn, C., & on behalf of the Better Diabetes Diagnosis Study Group
Affiliations
  • Lund University (SE)
  • Drottning Silvias barn- och ungdomssjukhus (SE)
  • University of Gothenburg (SE)
  • Linköping University (SE)
  • Karolinska Institutet (SE)
  • Linköping University Hospital (SE)
  • Department of Clinical Sciences; Lund University; Malmö Sweden
Corresponding author
Törn, Carina
Venue
Pediatric Diabetes
Publisher
Wiley
Published
2013-11-10
Volume
15
Issue
5
Pages
336-344
ISSN
1399-543X (ISSN-L)
OpenAlex
W1945765931
Cited by
44
References
52
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 5
FWCI
2.65
Type
journal article
Language
en
Open access
Locations
  • Pediatric Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • National Institute for Health Research (DK63861)
  • Knut and Alice Wallenberg Foundation
  • Lion Club International District 101-S
  • Sk�ne County Council Foundation for Research and Development
  • The Swedish Child Diabetes Foundation
  • The Swedish Diabetes Association Research Fund
  • The Swedish Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
islet cell antibodies, type 1 diabetes, pediatric diabetes, islet autoimmunity, glutamic acid decarboxylase antibodies, insulin autoantibodies, zinc transporter 8 antibodies, autoantigens, diagnostic sensitivity
MeSH terms
Adolescent, Autoantibodies, Autoantigens, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Glutamate Decarboxylase, Humans, Infant, Insulin, Islets of Langerhans, Male, Sweden, Autoimmunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review